Temporal lobe epilepsy (TLE) is a chronic neurological condition characterized by recurrent, unprovoked seizures originating in the temporal lobes of the brain. When medications fail to control these seizures, surgical intervention—typically an anterior temporal lobectomy (ATL)—becomes the primary treatment option. However, achieving long-term seizure freedom remains a challenge, as surgeons often struggle to determine the exact extent of tissue removal required for optimal outcomes.
Recent research indicates that neocortical hypometabolism in TLE follows a highly organized spatial gradient, where metabolic activity decreases in a predictable pattern moving away from the hippocampal-neocortical interface. A large-scale multicenter study published on medRxiv suggests that this gradient is not random; rather, it is deeply linked to the brain’s underlying cytoarchitectural structure and microstructural integrity (medRxiv, 2026). By mapping these metabolic patterns, clinicians may be able to move toward more personalized surgical strategies that prioritize the resection of areas with the most severe metabolic dysfunction.
Neocortical hypometabolism refers to a reduction in glucose metabolism in the brain's outer layer, which can be visualized using FDG-PET imaging. In the context of TLE, this hypometabolism is not limited to the seizure focus but radiates outward, following a distinct topographical gradient. This spatial organization is strongly correlated with the distance from the hippocampal-neocortical interface, with a statistical correlation reported at r = 0.955 (Pperm < 0.001) (medRxiv, 2026).
The intensity of this metabolic "dip" is tied to the brain's structural architecture. Regions closer to the interface, which typically exhibit lower cytoarchitectonic differentiation, show the most significant metabolic deficits. Furthermore, these same regions often display stronger FLAIR-related alterations on MRI scans, indicating that metabolic dysfunction and structural tissue changes are tightly coupled. This suggests that the hypometabolic gradient serves as a biological marker for the extent of the epileptic network beyond the hippocampus itself.
For patients undergoing anterior temporal lobectomy, the goal is to remove the specific tissue responsible for generating seizures while preserving healthy, functional brain matter. The presence of a quantifiable hypometabolic gradient provides a new metric to guide this decision-making process. Research findings indicate that the degree of overlap between the resection area and the region of severe hypometabolism is a significant predictor of post-surgical seizure freedom (OR = 1.448, P = 0.022) (medRxiv, 2026).
If the surgical plan removes a larger proportion of the most severely affected hypometabolic tissue, the patient is statistically more likely to achieve long-term seizure freedom. Conversely, leaving behind regions that show high levels of metabolic disruption may explain why some patients continue to experience seizures even after a standard lobectomy. This evidence suggests that surgeons should not rely solely on the visible hippocampal pathology but should integrate PET-derived metabolic mapping into their preoperative planning to better define the margins of the resection.
Keep exploring
More from GroundworkThe hippocampus is the primary epicenter for many TLE cases, but it does not act in isolation. The study demonstrates a distance-dependent coupling between hippocampal abnormalities and neocortical metabolism (r = 0.871, Pperm < 0.001) (medRxiv, 2026). This means that as the structural integrity of the hippocampus declines, the metabolic health of the connected neocortex declines in a predictable, distance-dependent fashion.
This connection highlights the importance of viewing TLE as a network-level disorder rather than a localized lesion. The "gradient" acts as a bridge between the deep-brain structures (like the hippocampus) and the cortical surface. When surgeons evaluate a patient for epilepsy surgery, the severity of the hippocampal changes should be interpreted in light of the broader neocortical hypometabolic profile to determine the necessary scope of the surgery.
Implementing these findings into clinical practice requires moving beyond standard visual inspections of neuroimaging. Surgeons and radiologists can collaborate to derive vertex-wise structural and metabolic features, using normative asymmetry modeling to quantify exactly how much a patient’s brain metabolism deviates from healthy standards. This creates a "map" of the epileptic network that is unique to the individual patient.
By identifying the specific topographical boundaries where the metabolic gradient fades, surgical teams can tailor their resection margins. This approach is particularly valuable for candidates whose seizure networks might be more extensive than traditional MRI findings suggest. As evidenced by the prospective validation cohort of 38 patients, this gradient-informed approach consistently correlates with better surgical results, offering a more biologically grounded framework for deciding how much of the temporal neocortex to remove (medRxiv, 2026).
If you or a loved one are considering surgery for drug-resistant epilepsy, the next step involves a comprehensive evaluation at an epilepsy center that utilizes advanced neuroimaging. Ask your neurologist if your surgical plan includes an analysis of neocortical metabolic gradients. While standard PET scans are common, the specific quantitative mapping of the hypometabolic gradient is an evolving practice that may require specialized neuroimaging analysis.
- Confirm that your surgical team is using multimodal imaging (MRI combined with FDG-PET).
- Discuss whether quantitative metabolic asymmetry analysis is available to define your seizure network.
